Biomedical engineering society (bmes) cellular and molecular bioengineering (cmbe) 2027-2029 annual meetings
Active Project Grant Awarded Last action
- Award ID
- R13EB040165
- Recipient
-
Biomedical Engineering Society UEI SSMNEHNM5894
- Awarding agency
-
National Institute of Biomedical Imaging and Bioenginering
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,000
Award facts
- Assistance listing
- 93.394 Cancer Detection and Diagnosis Research
- Completion date 4% complete
- Funding agency
- National Cancer Institute National Institutes of Health, Department of Health and Human Services
- Place of performance
- Arlington, VA 22209, USA
Award details come from USAspending.gov.
Description
- Abstract
- The goal of this application is to support travel awards for students, postdoctoral fellows, and early-stage investigators (ESI) to attend the 2027-29 biomedical engineering society (bmes) cellular and molecular bioengineering (cmbe) conferences. Broadly the goal of cmbe conference is to catalyze 1) the development of new molecular, cellular, bioimaging, synthetic biology, and single-cell technologies for probing and manipulating cellular dynamics and function, 2) the application and transition of these cutting edge approaches for understanding the organizing principles of complex cellular and tissue systems across scales, and 3) the translation of these advancements in ways that ultimately benefit humanity, such as actionable models of biological processes, drug screening systems, cellular biosensors, and advanced in vitro models to recapitulate biological process and enable discovery. The theme of the 2027 bmes cmbe conference is "mechanisms to medicine: engineering across biological scales". With the 2027 conference, we aim to focus on an integrated viewpoint of complex biological systems from basic mechanisms to clinical translational using "mechanisms to medicine" as a framework. Speakers will describe their engineering approaches to deconvolve the complex molecular, cellular, and tissue systems within the human body through quantitative and modeling approaches, including cutting edge in vitro systems. We have recruited several established and emerging research leaders in key defining research areas with strong focus on understanding and directing cell states in development and diseases, with particular focus on metabolism and other multiscale "omics", non-animal microphysiological models, and in silico biology, and their applications via biomanufacturing and clinical translation (see agenda). Our choices of theme and invited speakers will seed convergence research at the cutting edge of cellular and molecular biology and engineering. We hope the identified keynote and invited speakers will help inspire the next-generation of cellular and molecular bioengineers to adopt multidisciplinary approaches that broaden the scope of their science and apply the most innovative and cutting technologies - from in silico, to non-animal in vitro models, to clinical translation - to advance human health.
Quick answers
Who received award R13EB040165?
R13EB040165 was awarded to Biomedical Engineering Society by National Institute of Biomedical Imaging and Bioenginering (National Institutes of Health) on September 1, 2026.
How much is award R13EB040165 worth?
$3,000 has been obligated on R13EB040165.
Which agency awarded R13EB040165?
National Institute of Biomedical Imaging and Bioenginering (National Institutes of Health) awarded R13EB040165, with funding from National Cancer Institute (National Institutes of Health).
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award